Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.41% | -3.95% | -2.47% | 0.28% | -2.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.41% | -3.95% | -2.47% | 0.28% | -2.20% |
| Cost of Revenue | 1.64% | 0.16% | 0.35% | 4.30% | 4.14% |
| Gross Profit | -5.56% | -5.73% | -3.75% | -1.40% | -4.67% |
| SG&A Expenses | -11.86% | -8.84% | -7.51% | -6.63% | -6.01% |
| Depreciation & Amortization | 2.38% | -2.25% | 5.03% | 5.94% | -1.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.24% | -5.39% | -3.18% | -1.96% | -2.79% |
| Operating Income | 37.58% | 25.06% | 11.30% | 36.03% | 12.16% |
| Income Before Tax | 47.67% | 6.21% | 45.32% | 30.21% | -54.55% |
| Income Tax Expenses | 191.61% | 112.84% | 116.41% | -3,660.92% | -191.67% |
| Earnings from Continuing Operations | 45.60% | -19.13% | 31.37% | 48.06% | -48.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.60% | -19.13% | 31.37% | 48.06% | -48.78% |
| EBIT | 37.58% | 25.06% | 11.30% | 36.03% | 12.16% |
| EBITDA | 196.46% | 637.50% | 161.17% | 143.42% | -20.25% |
| EPS Basic | 47.07% | -15.72% | 33.27% | 49.54% | -44.23% |
| Normalized Basic EPS | 41.39% | -7.02% | -1.96% | 43.27% | -14.85% |
| EPS Diluted | 47.07% | -15.72% | 33.27% | 49.54% | -44.23% |
| Normalized Diluted EPS | 41.39% | -7.02% | -1.96% | 43.27% | -14.85% |
| Average Basic Shares Outstanding | 2.79% | 2.90% | 2.85% | 2.93% | 3.17% |
| Average Diluted Shares Outstanding | 2.79% | 2.90% | 2.85% | 2.93% | 3.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |